NSE · NATHBIOGEN
Nath Bio-Genes (India) Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,234
of 5,004 stocks
🏆 New peak
▲ 231W
Peak #2,234 · 01 Oct 2026
A microcap name in Chemicals, Nath Bio-Genes (India) Limited trades at an undemanding earnings multiple, is growing revenue at a solid clip, and posts a modest return on equity.
Market Cap
271.40 Cr
P/E Ratio
6.81
P/B Ratio
0.40
ROE
6.12%
ROCE
8.01%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 328.40 Cr | 51.59 Cr | 65.96 Cr | 43.85 Cr |
| Net Profit | 32.26 Cr | -Rs 92,000 | 1.60 Cr | 2.75 Cr |
| EPS | 16.98 | -0.79 | 0.84 | 1.40 |
| Operating Profit | 36.05 Cr | 5.83 Cr | 4.33 Cr | 7.05 Cr |
Shareholding pattern
Promoter
45.60%
Public
54.40%
Mutual fund holdings
₹2.08
Cr total
1
Schemes
1
Fund Houses
₹2.08 Cr
Total Exposure
Aditya Birla Sun Life Mutual Fund₹2.08 Cr (100.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 14 Aug 2025 | Dividend | Dividend - Rs 2 Per Share |
| 12 Aug 2024 | Other | Annual General Meeting |
| 09 Aug 2024 | Dividend | Dividend - Rs 2 Per Share |
| 07 Mar 2024 | Other | Extra- Ordinary General Meeting |
| 04 Jul 2023 | Dividend | Annual General Meeting/Dividend - Rs 2 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.